» Articles » PMID: 30480100

Big Bottlenecks in Cardiovascular Tissue Engineering

Overview
Journal Commun Biol
Specialty Biology
Date 2018 Nov 28
PMID 30480100
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Although tissue engineering using human-induced pluripotent stem cells is a promising approach for treatment of cardiovascular diseases, some limiting factors include the survival, electrical integration, maturity, scalability, and immune response of three-dimensional (3D) engineered tissues. Here we discuss these important roadblocks facing the tissue engineering field and suggest potential approaches to overcome these challenges.

Citing Articles

Bridging the Gap: Advances and Challenges in Heart Regeneration from In Vitro to In Vivo Applications.

Watanabe T, Hatayama N, Guo M, Yuhara S, Shinoka T Bioengineering (Basel). 2024; 11(10).

PMID: 39451329 PMC: 11505552. DOI: 10.3390/bioengineering11100954.


Microvascular network based on the Hilbert curve for nutrient transport in thick tissue.

Wang Z, Liu X, Shi X, Wang Y Regen Biomater. 2024; 11:rbae094.

PMID: 39350955 PMC: 11441758. DOI: 10.1093/rb/rbae094.


The HH-GLI2-CKS1B network regulates the proliferation-to-maturation transition of cardiomyocytes.

Waldron C, Kelly L, Stan N, Kawakami Y, Abrahante J, Magli A Stem Cells Transl Med. 2024; 13(7):678-692.

PMID: 38761090 PMC: 11227970. DOI: 10.1093/stcltm/szae032.


The Edifice of Vasculature-On-Chips: A Focused Review on the Key Elements and Assembly of Angiogenesis Models.

Lim J, Fang H, Bupphathong S, Sung P, Yeh C, Huang W ACS Biomater Sci Eng. 2024; 10(6):3548-3567.

PMID: 38712543 PMC: 11167599. DOI: 10.1021/acsbiomaterials.3c01978.


A Review on the Applications of Natural Biodegradable Nano Polymers in Cardiac Tissue Engineering.

Aziz R, Falanga M, Purenovic J, Mancini S, Lamberti P, Guida M Nanomaterials (Basel). 2023; 13(8).

PMID: 37110959 PMC: 10145986. DOI: 10.3390/nano13081374.


References
1.
Kolesky D, Homan K, Skylar-Scott M, Lewis J . Three-dimensional bioprinting of thick vascularized tissues. Proc Natl Acad Sci U S A. 2016; 113(12):3179-84. PMC: 4812707. DOI: 10.1073/pnas.1521342113. View

2.
Nakane T, Masumoto H, Tinney J, Yuan F, Kowalski W, Ye F . Impact of Cell Composition and Geometry on Human Induced Pluripotent Stem Cells-Derived Engineered Cardiac Tissue. Sci Rep. 2017; 7:45641. PMC: 5377302. DOI: 10.1038/srep45641. View

3.
Iyer R, Chiu L, Reis L, Radisic M . Engineered cardiac tissues. Curr Opin Biotechnol. 2011; 22(5):706-14. PMC: 3169735. DOI: 10.1016/j.copbio.2011.04.004. View

4.
Masumoto H, Nakane T, Tinney J, Yuan F, Ye F, Kowalski W . The myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages. Sci Rep. 2016; 6:29933. PMC: 4951692. DOI: 10.1038/srep29933. View

5.
Ye L, Chang Y, Xiong Q, Zhang P, Zhang L, Somasundaram P . Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell. 2014; 15(6):750-61. PMC: 4275050. DOI: 10.1016/j.stem.2014.11.009. View